Finance

Lists
Why is AVBP down 5.00%?
Dive Deeper
AVBP:NASDAQ
Arrivent Biopharma Inc
$12.36
-5.00%
(-0.65) 1D
Nov 16, 12:05:47 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AVBP...
Open
$12.86
High
$13.14
Low
$12.36
Mkt. cap
639.30M
Avg. vol.
2.14M
Volume
111.63K
52-wk high
$35.83
52-wk low
$11.37
EPS
-$3.65
Shares outstanding
51.72M
No. of employees
77
Open
$12.86
High
$13.14
Low
$12.36
Mkt. cap
639.30M
Avg. vol.
2.14M
Volume
111.63K
52-wk high
$35.83
52-wk low
$11.37
EPS
-$3.65
Shares outstanding
51.72M
No. of employees
77
News stories
From web sources and news partners
About Arrivent Biopharma Inc
CEO-
Employees77
Founded2021
HeadquartersNewtown Square, Pennsylvania, United States
SectorHealth Care
IndustryBiotechnology
Analyst ratings
Based on 11 analysts giving stock ratings to AVBP in the past 3 months
Strong buy
Buy
11
Hold
0
Sell
0
12-month forecast
Based on 11 Wall Street analysts offering 12 month price targets for AVBP in the last 3 months.
Highest
Current $12.36
$29.00 (+134.63%)
Average
$24.00 (+94.17%)
Lowest
$15.00 (+21.36%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Schmidt
Guggenheim
Buy
Maintained
$28.00
+126.5%
11/16/2026
Yigal Nochomovitz
Citi
Buy
Maintained
$23.00
+86.1%
11/11/2026
Supawat Thongthip
Truist Financial
Buy
Maintained
$24.00
+94.2%
11/10/2026
Boris Peaker
JonesTrading
Buy
Maintained
$22.00
+78%
11/10/2026
Jeff Jones
Oppenheimer
Buy
Maintained
$25.00
+102.3%
11/10/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
$27.00
+118.4%
11/10/2026
Jeet Mukherjee
BTIG
Buy
Maintained
$29.00
+134.6%
11/09/2026
Kaveri Pohlman
Clear Street
Buy
Maintained
-
-
10/25/2026
Mayank Mamtani
B. Riley Securities
Buy
Maintained
$29.00
+134.6%
10/20/2026
Kelly Shi
Jefferies
Buy
Maintained
$18.00
+45.6%
10/06/2026
Sam Slutsky
LifeSci Capital
Buy
Maintained
$15.00
+21.4%
10/06/2026
Asthika Goonewardene
Leerink Partners
Buy
Maintained
$45.00
+264.1%
08/13/2026
Soumit Roy
JonesTrading
Buy
Maintained
$45.00
+264.1%
04/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
-
-
-
5.00M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
32.18M
37.62M
42.34M
38.90M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.65M
8.49M
10.35M
9.48M
Operating expense
38.82M
46.11M
52.69M
48.38M
Total operating expenses
38.82M
46.11M
52.69M
48.38M
Operating income
-38.82M
-46.11M
-52.69M
-43.38M
Other non operating income
-
-
-
-
EBT including unusual items
-35.96M
-43.32M
-49.89M
-40.51M
EBT excluding unusual items
-35.54M
-43.32M
-49.89M
-40.31M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-35.96M
-43.32M
-49.89M
-40.51M
Net profit margin
-
-
-
-810.24%
Earnings per share
-0.78
-0.96
-1.05
-0.81
Interest and investment income
3.28M
2.79M
2.80M
3.06M
Interest expense
-
-
-
-
Net interest expenses
3.28M
2.79M
2.80M
3.06M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps